246 related articles for article (PubMed ID: 24863185)
1. Management of chronic hepatitis B in children: an unresolved issue.
Della Corte C; Nobili V; Comparcola D; Cainelli F; Vento S
J Gastroenterol Hepatol; 2014 May; 29(5):912-9. PubMed ID: 24863185
[TBL] [Abstract][Full Text] [Related]
2. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
Triolo M; Della Corte C; Colombo M
Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of hepatitis B infection: a brief review.
Quan DJ
Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
[TBL] [Abstract][Full Text] [Related]
4. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
Buster EH; Janssen HL
Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
Singal AK; Salameh H; Kuo YF; Fontana RJ
Aliment Pharmacol Ther; 2013 Jul; 38(2):98-106. PubMed ID: 23713520
[TBL] [Abstract][Full Text] [Related]
6. Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.
Leung N
Liver Int; 2011 Jan; 31 Suppl 1():85-9. PubMed ID: 21205143
[TBL] [Abstract][Full Text] [Related]
7. Analogs and fibrosis regression in hepatitis B.
Bourlière M; Kahloun A; Gascou-Tessonnier G
Gastroenterol Clin Biol; 2009; 33(10-11):923-9. PubMed ID: 19640665
[TBL] [Abstract][Full Text] [Related]
8. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options.
Jonas MM; Block JM; Haber BA; Karpen SJ; London WT; Murray KF; Narkewicz MR; Rosenthal P; Schwarz KB; McMahon BJ;
Hepatology; 2010 Dec; 52(6):2192-205. PubMed ID: 20890947
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
Lindh M; Uhnoo I; Bläckberg J; Duberg AS; Friman S; Fischler B; Karlström O; Norkrans G; Reichard O; Sangfeldt P; Söderström A; Sönnerborg A; Weiland O; Wejstål R; Wiström J
Scand J Infect Dis; 2008; 40(6-7):436-50. PubMed ID: 18584530
[TBL] [Abstract][Full Text] [Related]
10. Antiviral options for the treatment of chronic hepatitis B.
Osborn MK; Lok AS
J Antimicrob Chemother; 2006 Jun; 57(6):1030-4. PubMed ID: 16595637
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.
Arora G; Keeffe EB
Rev Gastroenterol Disord; 2007; 7(2):63-73. PubMed ID: 17597674
[TBL] [Abstract][Full Text] [Related]
12. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
Chien RN
J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
[TBL] [Abstract][Full Text] [Related]
13. Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.
Sims KA; Woodland AM
Pharmacotherapy; 2006 Dec; 26(12):1745-57. PubMed ID: 17125436
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy in patients with chronic hepatitis B and cirrhosis.
Lai CJ; Terrault NA
Gastroenterol Clin North Am; 2004 Sep; 33(3):629-54, x-xi. PubMed ID: 15324948
[TBL] [Abstract][Full Text] [Related]
15. Review article: current antiviral therapy of chronic hepatitis B.
Ayoub WS; Keeffe EB
Aliment Pharmacol Ther; 2008 Jul; 28(2):167-77. PubMed ID: 18466358
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis B--treatment with nucleoside analogues.
Leung N
Med J Malaysia; 2005 Jul; 60 Suppl B():22-7. PubMed ID: 16108169
[TBL] [Abstract][Full Text] [Related]
17. [Progress and perspectives in treatment of chronic hepatitis B].
Minami M; Okanoue T
Nihon Rinsho; 2011 Apr; 69(4):737-41. PubMed ID: 21591432
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B.
Asselah T; Marcellin P
Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815
[TBL] [Abstract][Full Text] [Related]
19. [Chronic hepatitis B: current therapy].
Buffet C
Bull Acad Natl Med; 2008 Nov; 192(8):1625-37; discussion 1638-9. PubMed ID: 19445377
[TBL] [Abstract][Full Text] [Related]
20. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
